4DMedical (FRA:MQ7) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MQ7 4DMedical Ltd FRA:MQ7
42 GF Score
Price €1.82
GF Value €0.83
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is 4DMedical FFO per Share?

FFO per Share only applies to REITs.

FRA:MQ7
42GF Score
4DMedical Ltd FRA:MQ7
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 4DMedical (FRA:MQ7) Overvalued in 2026?

Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued. The current stock price of €1.82 is trading 119.3% above its estimated GF Value™ of €0.83. GuruFocus considers 4DMedical to be Significantly Overvalued.

Key valuation signals for FRA:MQ7:

  • FFO per Share:
  • GF Value™: €0.83 vs. price of €1.82 (119.3% above fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the FRA:MQ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


4DMedical Business Description

Other Exchanges FDMDF:USA4DX:Australia
Address 700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
42GF Score

Get the complete analysis for FRA:MQ7

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.82
Price
€0.83
GF Value